TrademarkOpen
Search / United States / 97507484

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

KERNAL

Allowed — statement of use stage
Third Extension - Granted
Used for: Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product…
Show more

Class 1: Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Biochemicals for use in biotechnological manufacturing processes and product development, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids related to treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; nucleotides for scientific and research use; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; protein arrays and nucleotide arrays for scientific and medical research; nucleic acid for laboratory…
Class 5: Medical, biological, and pharmaceutical preparations for treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; medical, biological and pharmaceutical preparations containing lipid nanoparticles for the prevention and treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents…

Class 1 – ChemicalsClass 5 – Pharmaceuticals & supplements

Status timeline

  1. 21 Jul 2022
    Application filed
    New Application Entered
  2. 3 May 2023
    Assigned to an examining attorney
    Assigned To Examiner
  3. 3 May 2023
    Office action issued
    Non-Final Action Written
  4. 30 Oct 2023
    Response to office action filed
    Teas Response To Office Action Received
  5. 4 Dec 2023
    Final refusal issued
    Final Refusal Mailed
  6. 1 Aug 2024
    Approved for publication
    Approved For Pub - Principal Register
  7. 3 Sep 2024
    Published for opposition
    Published For Opposition
  8. 29 Oct 2024
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  9. 21 Apr 2025
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  10. 28 Oct 2025
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  11. 28 Apr 2026
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 40 events
2026-04-28Sou Extension 3 Granted
2026-04-28Notice Of Approval Of Extension Request E-Mailed
2026-04-27Sou Teas Extension Received
2026-04-27Sou Extension 3 Filed
2025-10-29Notice Of Approval Of Extension Request E-Mailed
2025-10-28Sou Teas Extension Received
2025-10-28Sou Extension 2 Filed
2025-10-28Sou Extension 2 Granted
2025-04-22Notice Of Approval Of Extension Request E-Mailed
2025-04-21Sou Teas Extension Received
2025-04-21Sou Extension 1 Filed
2025-04-21Sou Extension 1 Granted
2024-10-29Noa Mailed - Sou Required From Applicant
2024-09-03Published For Opposition
2024-09-03Official Gazette Publication Confirmation E-Mailed
2024-08-14Notification Of Notice Of Publication E-Mailed
2024-08-01Examiners Amendment -Written
2024-08-01Examiners Amendment E-Mailed
2024-08-01Notification Of Examiners Amendment E-Mailed
2024-08-01Examiner's Amendment Entered
2024-08-01Approved For Pub - Principal Register
2023-12-04Final Refusal Mailed
2023-12-04Final Refusal E-Mailed
2023-12-04Notification Of Final Refusal Emailed
2023-10-30Teas Response To Office Action Received
2023-10-30Correspondence Received In Law Office
2023-10-30Teas/Email Correspondence Entered
2023-10-18Teas Change Of Owner Address Received
2023-10-18Applicant/Correspondence Changes (Non-Responsive) Entered
2023-10-18Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2023-10-18Attorney/Dom.rep.revoked And/Or Appointed
2023-10-18Teas Change Of Correspondence Received
2023-07-21Application Extension To Response Period - Received
2023-07-21Application Extension Granted/Receipt Provided
2023-05-03Assigned To Examiner
2023-05-03Non-Final Action Written
2023-05-03Non-Final Action E-Mailed
2023-05-03Notification Of Non-Final Action E-Mailed
2022-08-08New Application Office Supplied Data Entered
2022-07-21New Application Entered

Goods & services by class

Class 1 Chemicals

Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Biochemicals for use in biotechnological manufacturing processes and product development, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids related to treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; nucleotides for scientific and research use; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; protein arrays and nucleotide arrays for scientific and medical research; nucleic acid for laboratory…

Class 5 Pharmaceuticals & supplements

Medical, biological, and pharmaceutical preparations for treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; medical, biological and pharmaceutical preparations containing lipid nanoparticles for the prevention and treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents…

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 29 Apr 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.